Results overview: Found 10 records in 0.01 seconds.
Articles, 10 records found
Articles 10 records found  
1.
7 p, 793.0 KB Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation : A retrospective analysis of the EBMT chronic malignancies working party / Scheid, C. (University of Cologne) ; De Wreede, L. (DKMS. German Bone Marrow Donor Center) ; Van Biezen, A. (Leiden University Medical Center) ; Koenecke, C. (Hannover Medical School) ; Göhring, G. (Hannover Medical School) ; Volin, L. (HUCH Comprehensive Cancer Center) ; Maertens, J. (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Finke, J. (University of Freiburg) ; Passweg, J. (University Hospital) ; Beelen, D. (University Hospital) ; Cornelissen, J. J. (University Medical Center Rotterdam) ; Itälä-Remes, M. (Turku University Hospital (Finlàndia)) ; Chevallier, P. (CHU Nantes) ; Russell, N. (Nottingham University) ; Petersen, E. (University Medical Centre) ; Milpied, N. (Hôpital Haut-leveque) ; Richard Espiga, C. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Peniket, A. (Churchill Hospital) ; Sierra Llopart, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Mufti, G. (GKT School of Medicine) ; Crawley, C. (Addenbrookes Hospital (Cambridge, Regne Unit)) ; Veelken, J.H. (Leiden University Hospital) ; Ljungman, P. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Cahn, Jean-Yves (Hopital A. Michallon) ; Alessandrino, E.P. (Fondazione IRCCS Policlinico San Matteo) ; De Witte, T. (Radboud University-Nijmegen Medical Centre) ; Robin, M. (Hopital St. Louis) ; Kröger, N. (University Hospital Eppendorf) ; Universitat Autònoma de Barcelona
The International Prognostic Scoring System has been revised (IPSS-R) to predict prognosis of patients with myelodysplastic syndromes at diagnosis. To validate the use of the IPSS-R assessed before transplant rather than at diagnosis we performed a retrospective analysis of the EBMT database. [...]
2017 - 10.1038/bmt.2017.171
Bone marrow transplantation, Vol. 52 Núm. 11 (january 2017) , p. 1519-1525  
2.
19 p, 824.2 KB Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL) / Maschmeyer, Georg (Klinikum Ernst von Bergmann) ; De Greef, Julien (Henri Mondor Teaching Hospital) ; Mellinghoff, Sibylle C. (University of Cologne) ; Nosari, Annamaria (ASST Grande Ospedale Metropolitano Niguarda) ; Thiebaut-Bertrand, Anne (Université Grenoble Alpes) ; Bergeron, Anne (APHP Saint-Louis Hospital) ; Franquet, Tomas (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Blijlevens, Nicole M.A. (Radboud University Medical Centre) ; Maertens, Johan A. (University of Leuven) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
A multitude of new agents for the treatment of hematologic malignancies has been introduced over the past decade. Hematologists, infectious disease specialists, stem cell transplant experts, pulmonologists and radiologists have met within the framework of the European Conference on Infections in Leukemia (ECIL) to provide a critical state-of-the-art on infectious complications associated with immunotherapeutic and molecular targeted agents used in clinical routine. [...]
2019 - 10.1038/s41375-019-0388-x
Leukemia, Vol. 33 Núm. 4 (january 2019) , p. 844-862  
3.
13 p, 1.7 MB A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation / Cremers, E.M.P. (VU University Medical Centre) ; de Witte, T. (Radboud University Medical Centre) ; de Wreede, Liesbeth C. (Leiden University Medical Center) ; Eikema, D.J. (EBMT Statistical Unit Data Office Leiden) ; Koster, L. (EBMT Data Office Leiden) ; van Biezen, A. (EBMT Data Office Leiden) ; Finke, J. (University of Freiburg) ; Socié, G. (Hospital St. Louis) ; Beelen, D. (University Hospital) ; Maertens, J. (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Nagler, A. (Chaim Sheba Medical Center (Israel)) ; Kobbe, G. (Heinrich Heine Universitaet) ; Ziagkos, D. (EBMT Statistical Unit Data Office Leiden) ; Itälä-Remes, M. (HUCH Comprehensive Cancer Center) ; Gedde-Dahl, T. (Oslo University Hospital (Oslo, Noruega)) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Niederwieser, D. (University Hospital Leipzig) ; Ljungman, P. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Beguin, Y. (University of Liège) ; Ozkurt, Z.N. (Gazi University) ; Anagnostopoulos, Achilles (George Papanicolaou General Hospital (Tessalònia, Grècia)) ; Jindra, P. (Charles University Hospital) ; Robin, M. (Hospital St. Louis) ; Kröger, N. (University Hospital Eppendorf) ; Universitat Autònoma de Barcelona
Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. [...]
2019 - 10.1080/10428194.2019.1594215
Leukemia and Lymphoma, Vol. 60 Núm. 10 (2019) , p. 2404-2414  
4.
15 p, 694.5 KB Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms : results from the EPICOVIDEHA registry / Marchetti, Monia (Azienda Ospedaliera Nazionale) ; Salmanton-García, Jon (University of Cologne, Cologne, Germany) ; El-Ashwah, Shaimaa (Mansoura University. Oncology Center) ; Verga, Luisa (Università Milano-Bicocca) ; Itri, Federico (San Luigi Gonzaga Hospital-Orbassano, Orbassano, Italy) ; Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion, Prague, Czech Republic) ; Dávila-Valls, Julio (Hospital Nuestra Señora de Sonsoles (Àvila)) ; Martín-Pérez, Sonia (Hospital Nuestra Señora de Sonsoles (Àvila)) ; Van Doesum, Jaap (University Medical Center Groningen, The Netherlands) ; Passamonti, Francesco (University Insubria, Varese, Italy) ; Abu-Zeinah, Ghaith (Division of Hematology and Oncology, Weill Cornell Medicine, New York) ; Farina, Francesca (IRCCS Ospedale San Raffaele, Milan, Italy) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome) ; Cattaneo, Chiara (Hematology Unit, ASST-Spedali Civili, Brescia, Italy) ; Gomes Da Silva, Maria (Portuguese Institute of Oncology, Lisbon, Portugal) ; Bilgin, Yavuz M. (Department of Internal Medicine, ADRZ, Goes, The Netherlands) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Petzer, Verena (Medical University of Innsbruck, Austria) ; Glenthøj, Andreas (Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark) ; Espigado, Ildefonso (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Buquicchio, Caterina (Ospedale Dimiccoli Barletta, Italy) ; Bonuomo, Valentina (University of Verona, Italy) ; Prezioso, Lucia (Hospital University of Parma, Italy) ; Meers, Stef (AZ KLINA, Brasschaat, Belgium) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Bergantim, Rui ; Jakšić, Ozren ; Čolović, Natasha ; Blennow, Ola ; Cernan, Martin ; Schönlein, Martin ; Samarkos, Michail ; Mitra, Maria Enza ; Magliano, Gabriele ; Maertens, Johan ; Ledoux, Marie-Pierre ; Jiménez, Moraima (Hospital Universitari Vall d'Hebron) ; Demirkan, Fatih ; Collins, Graham ; Cabirta, Alba (Hospital Universitari Vall d'Hebron) ; Gräfe, Stefanie K. ; Nordlander, Anna ; Wolf, Dominik ; Arellano, Elena ; Cordoba, Raul ; Hanakova, Michaela ; Zambrotta, Giovanni ; Nunes Rodrigues, Raquel ; Limberti, Giulia ; Marchesi, Francesco ; Cornely, Oliver A. ; Pagano, Livio ; Universitat Autònoma de Barcelona
Patients with Philadelphia-negative chronic myeloproliferative neoplasms (MPN) typically incur high rates of infections and both drugs and comorbidities may modulate infection risk. The present study aims to assess the effect of immunosuppressive agents on clinical outcomes of MPN patients affected by the coronavirus disease 2019 (COVID-19). [...]
2023 - 10.1177/20406207231154706
Therapeutic Advances in Hematology, Vol. 14 (march 2023)  
5.
9 p, 1.5 MB Outcome of COVID-19 in allogeneic stem cell transplant recipients : Results from the EPICOVIDEHA registry / Busca, Alessandro (AOU Citta' della Salute e della Scienza) ; Salmanton-García, Jon (University of Cologne) ; Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ; Farina, Francesca (IRCCS Ospedale San Raffaele) ; Seval, Guldane Cengiz (Ankara University) ; Van Doesum, Jaap (University Medical Center Groningen) ; De Jonge, Nick (Amsterdam UMC) ; Bahr, Nathan C. (University of Kansas Medical Center) ; Maertens, Johan (K.U. Leuven and Department of Hematology) ; Meletiadis, Joseph ("Attikon" University General Hospital) ; Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Weinbergerová, Barbora (Department of Internal Medicine - Hematology and Oncology, Masaryk University Hospital Brno) ; Verga, Luisa (Università Milano-Bicocca) ; Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion) ; Jiménez, Moraima (Universitat Autònoma de Barcelona. Departament de Medicina) ; Glenthøj, Andreas (Copenhagen University Hospital) ; Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Tanase, Alina Daniela (University of Medicine and Pharmacy Carol Davila) ; Schönlein, Martin (University Medical Center Hamburg-Eppendorf. Department of Oncology, Hematology and Bone Marrow Transplantation) ; Prezioso, Lucia (Hospital University of Parma - Hematology and Bone Marrow Unit) ; Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Nucci, Marcio (Federal University of Rio de Janeiro) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Kulasekararaj, Austin (King's College London) ; Espigado, Ildefonso (Instituto de Biomedicina de Sevilla) ; De Kort, Elizabeth (Radboudumc) ; Ribera-Santa Susana, José-María (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Marchetti, Monia (Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo) ; Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda) ; Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ; Ilhan, Osman (Ankara University) ; Ammatuna, Emanuele (University Medical Center Groningen) ; Zompi, Sofia (Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza) ; Tsirigotis, Panagiotis (National and Kapodistrian University of Athens. "Attikon" University General Hospital) ; Antoniadou, Anastasia (National and Kapodistrian University of Athens. "Attikon" University General Hospital) ; Zambrotta, Giovanni (Università Milano-Bicocca) ; Nordlander, Anna (Department of Infectious Diseases, Karolinska University Hospital) ; Karlsson, Linda Katharina (University of Copenhagen) ; Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ; Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli - IRCCS) ; Cabirta, Alba (Vall d'Hebron Institut d'Oncologia) ; Berg Venemyr, Caroline (Copenhagen University Hospital - Rigshospitalet) ; Gräfe, Stefanie (University of Cologne) ; Van Praet, Jens (AZ Sint-Jan Brugge-Oostende AV. Department of Nephrology and Infectious diseases) ; Tragiannidis, Athanasios (Aristotle University of Thessaloniki) ; Petzer, Verena (Medical University of Innsbruck. Department of Hematology and Oncology) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (Madrid)) ; Itri, Federico (San Luigi Gonzaga Hospital - Orbassano) ; Groh, Ana (Infektiologie, Universitätsklinikum Frankfurt am Main) ; Gavriilaki, Eleni (General Hospital of Thessaloniki "George Papanikolaou") ; Dargenio, Michelina (Hematology and Stem Cell Transplant Unit) ; Rahimli, Laman (University of Cologne) ; Cornely, Oliver A. (German Centre for Infection Research (DZIF)) ; Pagano, Livio (Università Cattolica del Sacro Cuore)
The outcome of COVID-19 in allogeneic hematopoietic stem cell transplantation (HSCT) recipients is almost uniformely considered poor. The aim of present study was to retrospectively analyse the outcome and risk factors for mortality in a large series of patients who developed COVID-19 infection after an allogeneic HSCT. [...]
2023 - 10.3389/fimmu.2023.1125030
Frontiers in immunology, Vol. 14 (february 2023)  
6.
11 p, 1.2 MB A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients / Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ; Bermúdez, Arancha (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Logan, Aaron C. (Division of Hematology and Blood and Marrow Transplantation. Department of Medicine. University of California) ; Kharfan-Dabaja, Mohamed A. (Department of Blood and Marrow Transplantation. H. Lee Moffitt Cancer Center and Research Institute and University of South Florida) ; Chevallier, Patrice (Service d'Hématologie Clinique. CHU de Nantes. 44093. Nantes. France and CRCINA / INSERM UMR1232 / CNRS ERL6001 IRS UN - 8) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Wulf, Gerald (Department of Hematology and Medical Oncology. University Medical Center Göttingen) ; Selleslag, Dominik (Department of Hematology. AZ Sint-Jan Brugge-Oostende) ; Kakihana, Kazuhiko (Hematology Division. Tokyo Metropolitan Komagome Hospital) ; Langston, Amelia (Winship Cancer Institute. Emory University) ; Lee, Dong-Gun. (Division of Infectious Diseases. Department of Internal Medicine. Catholic Hematology Hospital and Seoul St. Mary's Hospital. College of Medicine. The Catholic University of Korea) ; Solano, Carlos (Instituto de Investigación Sanitaria INCLIVA (València, Comunitat Valenciana)) ; Okamoto, Shinichiro (Division of Hematology. Department of Medicine. Kelo University School of Medicine) ; Smith, Larry R. (Vical) ; Boeckh, Michael (Vaccine and Infectious Disease Division. Fred Hutchinson Cancer Research Center and University of Washington) ; Wingard, John Reid (Division of Hematology & Oncology. Department of Medicine. University of Florida) ; Cywin, Beth (Astellas Pharma Global Development) ; Fredericks, Christine (Astellas Pharma Global Development) ; Lademacher, Christopher (Astellas Pharma Global Development) ; Wang, Xuegong (Astellas Pharma Global Development) ; Young, James (Astellas Pharma Global Development) ; Maertens, Johan (K.U. Leuven and Department of Hematology)
Background: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ASP0113, a DNA-based vaccine, contains two plasmids encoding human CMV glycoprotein B and phosphoprotein 65 (pp65). [...]
2021 - 10.1016/j.eclinm.2021.100787
EClinicalMedicine, Vol. 33 (march 2021) , p. 100787  
7.
12 p, 770.4 KB COVID-19 in adult acute myeloid leukemia patients : a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) / Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ; Salmanton-García, Jon (University of Cologne) ; Emarah, Ziad (Mansoura University) ; Piukovics, Klára (Medicine University of Szeged) ; Nucci, Marcio (Federal University of Rio de Janeiro) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Rácil, Zdenék (Institute of Hematology and Blood Transfusion) ; Farina, Francesca (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Popova, Marina (Pavlov University) ; Zompi, Sofia (AOU Citta' della Salute e della Scienza) ; Audisio, Ernesta (AOU Citta' della Salute e della Scienza) ; Ledoux, Marie-Pierre (Institut de Cancérologie Strasbourg Europe) ; Verga, Luisa (Università Milano-Bicocca) ; Weinbergerová, Barbora (University Hospital Brno (República Txeca)) ; Szotkovski, Tomas (University Hospital Olomouc (Olomouc, República Txeca)) ; Da Silva, Maria Gomes (Portuguese Institute of Oncology) ; Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; De Jonge, Nick (Amsterdam UMC) ; Collins, Graham (Oxford University Hospitals) ; Marchetti, Monia (Azienda Ospedaliera Nazionale "SS. Antonio e Biagio e Cesare Arrigo") ; Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda) ; Garcia-Vidal, Carolina (Universitat de Barcelona) ; Biernat, Monika M. (Wroclaw Medical University) ; Van Doesum, Jaap (University Medical Center Groningen) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Demirkan, Fatih (Dokuz Eylul University) ; Al-Khabori, Murtadha (Sultan Qaboos University Hospital) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Víšek, Benjamín (University Hospital Hradec Kralove (República Txeca)) ; Stoma, Igor (Gomel State Medical University, Gomel) ; Méndez, Gustavo-Adolfo (Hospital Escuela de Agudos Dr. Ramón Madariaga) ; Maertens, Johan (KU Leuven) ; Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ; Espigado, Ildefonso (Universidad de Sevilla) ; Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli) ; Fianchi, Luana (, Fondazione Policlinico Universitario Agostino Gemelli) ; Del Principe, Maria Ilaria (Tor Vergata University of Rome) ; Cabirta, Alba (Vall d'Hebron Institut d'Oncologia) ; Ormazabal-Vélez, Irati (Complejo Hospitalario de Navarra) ; Jakšić, Ozren (University Hospital Dubrava) ; Buquicchio, Caterina (Ematologia con Trapianto (Itàlia)) ; Bonuomo, Valentina (University of Verona) ; Batinié, Josip (University Hospital Centre Zagreb) ; Omrani, Ali S. (Hamad Medical Corporation) ; Lamure, Sylvain (Universite de Montpellier) ; Finizio, Olimpia (Università Cattolica del Sacro Cuore) ; Fernández, Noemí (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ; Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Bergantim, Rui (Centro Hospitalar e Universitário São João (Portugal)) ; Ali, Natasha (Aga Khan University Hospital) ; Win, Sein (Yangon General Hospital) ; Van Praet, Jens (AZ Sint-Jan Brugge-Oostende) ; Tisi, Maria Chiara (Ospedale San Bortolo) ; Shirinova, Ayten (Azerbaijan Scientific Research Hematology and Transfusiology Institute) ; Schönlein, Martin (University Medical Center Hamburg-Eppendorf) ; Prattes, Juergen (Medical University of Graz) ; Piedimonte, Monica (AOU Sant'Andrea) ; Petzer, Verena (Medical University of Innsbruck) ; Navrátil, Milan (University Hospital of Ostrava) ; Kulasekararaj, Austin (King's College Hospital NHS Foundation Trust) ; Jindra, Pavel (University Hospital Pilsen) ; Sramek, Jirí (University Hospital Pilsen) ; Glenthøj, Andreas (Copenhagen University Hospital) ; Fazzi, Rita (Azienda Ospedaliera Università Pisana) ; De Ramón-Sánchez, Cristina (Instituto de Investigación Biomédica de Salamanca) ; Cattaneo, Chiara (ASST-Spedali Civili) ; Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ; Bahr, Nathan C. (University of Kansas Medical Center) ; El-Ashwah, Shaimaa (Mansoura University) ; Cordoba, Raul (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ; Zambrotta, Giovanni (Azienda Ospedaliera San Gerardo) ; Zambrotta, Giovanni (Università Milano-Bicocca) ; Sciumè, Mariarita (IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Booth, Stephen (Oxford University Hospitals) ; Rodrigues, Raquel Nunes (Portuguese Institute of Oncology) ; Sacchi, Maria Vittoria (Azienda Ospedaliera Nazionale "SS. Antonio e Biagio e Cesare Arrigo") ; García-Poutón, Nicole (Universitat de Barcelona) ; Martín-González, Juan-Alberto (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Khostelidi, Sofya (North-Western State Medical University named after Iliá Ilich Méchnikov) ; Gräfe, Stefanie (University of Cologne) ; Rahimli, Laman (University of Cologne) ; Ammatuna, Emanuele (University Medical Center Groningen) ; Busca, Alessandro (AOU Citta' della Salute e della Scienza) ; Corradini, Paolo (University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori) ; Hoenigl, Martin (Medical University of Graz) ; Klimko, Nikolai (North-Western State Medical University named after Iliá Ilich Méchnikov) ; Koehler, Philipp (University of Cologne) ; Pagliuca, Antonio (King's College Hospital NHS Foundation Trust) ; Passamonti, Francesco (University of Insubria and ASST Sette Laghi) ; Cornely, Oliver A. (University of Cologne) ; Pagano, Livio (Università Cattolica del Sacro Cuore) ; Universitat Autònoma de Barcelona
Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients diagnosed with COVID-19 between February 2020 and October 2021. [...]
2022 - 10.3324/haematol.2022.280847
Haematologica, Vol. 108 (may 2022) , p. 22-33  
8.
15 p, 1.8 MB COVID-19 infection in adult patients with hematological malignancies : a European Hematology Association Survey (EPICOVIDEHA) / Pagano, Livio (Università Cattolica del Sacro Cuore) ; Salmanton-García, Jon (University of Cologne) ; Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ; Busca, Alessandro (AOU Citta' Della Salute E Della Scienza) ; Corradini, Paolo (University of Milan) ; Hoenigl, Martin (Medical University of Graz) ; Klimko, Nikolai (North-Western State Medical University Named After Iliá Ilich Méchnikov (Sant Petersburg, Rússia)) ; Koehler, Philipp (University of Cologne. Faculty of Medicine) ; Pagliuca, Antonio (King's College Hospital NHS Foundation Trust) ; Passamonti, Francesco (University of Insubria) ; Verga, Luisa (Università Milano-Bicocca) ; Víšek, Benjamin (University Hospital Hradec Kralove (República Txeca)) ; Ilhan, Osman (Ankara University) ; Nadali, Gianpaolo (Policlinico Borgo Roma Verona (Verona, Itàlia)) ; Weinbergerová, Barbora (University Hospital Brno (República Txeca)) ; Cordoba, Raul (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Marchetti, Monia (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo) ; Collins, Graham (NIHR Oxford Biomedical Research Centre) ; Farina, Francesca (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Cattaneo, Chiara (ASST-Spedali Civili) ; Cabirta, Alba (Hospital Universitari Vall d'Hebron) ; Gomes da Silva, Maria (Portuguese Institute of Oncology) ; Itri, Federico (San Luigi Gonzaga Hospital - Orbassano) ; van Doesum, Jaap A (University Medical Center Groningen) ; Ledoux, Marie-Pierre (ICANS) ; Čerňan, Martin (University Hospital Olomouc (Olomouc, República Txeca)) ; Jakšić, Ozren (University Hospital Dubrava) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda (Milà, Itàlia)) ; Omrani, Ali S. (Communicable Disease Center, Hamad Medical Corporation) ; Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Kulasekararaj, Austin (King's College London) ; Valković, Toni (University of Rijeka. Faculty of Medicine) ; Poulsen, Christian Bjørn (Zealand University Hospital) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Glenthøj, Andreas (University of Copenhagen) ; Stoma, Igor (Gomel State Medical University) ; Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion) ; Piukovics, Klára (University of Szeged. Department of Internal Medicine) ; Navrátil, Milan (University Hospital Ostrava) ; Emarah, Ziad (Mansoura University. Oncology Center) ; Sili, Uluhan (Marmara University) ; Maertens, Johan (KU Leuven) ; Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Bergantim, Rui (University of Porto) ; Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ; Prezioso, Lucia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ; Guidetti, Anna (Fondazione IRCCS Istituto Nazionale Dei Tumori) ; del Principe, Maria Ilaria (University of Rome Tor Vergata. Department of Biomedicine and Prevention) ; Popova, Marina (Pavlov University) ; De Jonge, Nick (Amsterdam UMC, Location VUmc) ; Ormazabal-Vélez, Irati (Complejo Hospitalario de Navarra) ; Fernández, Noemí (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ; Cuccaro, Annarosa (Azienda USL Toscana NordOvest (Livorno, Itàlia)) ; Meers, Stef (AZ Klina) ; Buquicchio, Caterina (Ematologia Con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy) ; Antić, Darko (University of Belgrade. Faculty of Medicine) ; Al-Khabori, Murtadha (Sultan Qaboos University Hospital) ; García-Sanz, Ramón (IBSAL, Centro de Investigación del Cáncer-IBMCC) ; Biernat, Monika M. (Wroclaw Medical University) ; Tisi, Maria Chiara (San Bortolo Hospital. Cell Therapy and Hematology) ; Sal, Ertan (University of Cologne, Faculty of Medicine and University Hospital Cologne. Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases) ; Rahimli, Laman (University of Cologne. Faculty of Medicine) ; Čolović, Natasa (University of Belgrade. Faculty of Medicine) ; Schönlein, Martin (University Medical Center Hamburg-Eppendorf. Department of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology) ; Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ; Tascini, Carlo (Azienda Sanitaria Universitaria del Friuli Centrale (Udine, Itàlia)) ; Miranda-Castillo, Carolina (Hospital Universitario Rey Juan Carlos (Madrid)) ; Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ; Méndez, Gustavo-Adolfo (Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina) ; Petzer, Verena (Medical University of Innsbruck. Department of Hematology and Oncology) ; Novák, Jan (University Hospital of Královské Vinohrady) ; Besson, Caroline (Centre Hospitalier de Versailles) ; Duléry, Rémy (Sorbonne Université) ; Lamure, Sylvain (Universite de Montpellier. Departement d'Hematologie Clinique) ; Nucci, Marcio (Federal University of Rio de Janeiro) ; Zambrotta, Giovanni (Università Milano-Bicocca) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Seval, Guldane Cengiz (Ankara University) ; Bonuomo, Valentina (Policlinico Borgo Roma Verona, Verona, Italy) ; Mayer, Jiří (University Hospital Brno (República Txeca)) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Sacchi, Maria Vittoria (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo. Hematology and BMT Unit) ; Booth, Stephen (NIHR Oxford Biomedical Research Centre, Churchill Hospital) ; Ciceri, Fabio (IRCCS San Raffaele Scientific Institute. Hematology and Bone Marrow Transplantation) ; Oberti, Margherita (ASST-Spedali Civili) ; Salvini, Marco (University of Insubria) ; Izuzquiza, Macarena (Universitat Autònoma de Barcelona. Departament de Medicina) ; Nunes-Rodrigues, Raquel (Portuguese Institute of Oncology) ; Ammatuna, Emanuele (University Medical Center Groningen) ; Obr, Aleš (Palacky University. University Hospital Olomouc) ; Herbrecht, Raoul (ICANS) ; Núñez-Martín-Buitrago, Lucía (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Mancini, Valentina (ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy) ; Shwaylia, Hawraa (National Center for Cancer Care and Research, Hamad Medical Corporation) ; Sciumè, Mariarita (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Essame, Jenna (King's College Hospital NHS Foundation Trust) ; Nygaard, Marietta (Zealand University Hospital) ; Batinić, Josip (University of Zagreb. Faculty of Medicine) ; Gonzaga, Yung (Instituto Nacional Do Cancer. Hematology Service) ; Regalado-Artamendi, Isabel (Hospital General Universitario Gregorio Marañón) ; Karlsson, Linda Katharina (University of Copenhagen) ; Shapetska, Maryia (Scientific and Practical Center for Surgery, Transplantology and Hematology (Mins, Bielorússia)) ; Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ; El-Ashwah, Shaimaa (Mansoura University. Oncology Center) ; Borbényi, Zita (University of Szeged. Department of Internal Medicine) ; Çolak, Gökçe Melis (Marmara University) ; Nordlander, Anna (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Dragonetti, Giulia (Università Cattolica del Sacro Cuore) ; Maraglino, Alessio Maria Edoardo (Università Cattolica del Sacro Cuore) ; Rinaldi, Amelia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ; De Ramón-Sánchez, Cristina (Instituto de Investigación Biomédica de Salamanca) ; Cornely, Oliver A. (German Centre for Infection Research (DZIF))
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. [...]
2021 - 10.1186/s13045-021-01177-0
Journal of hematology & oncology, Vol. 14 (october 2021)  
9.
8 p, 732.8 KB Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation / Gagelmann, N. (University Medical Center Hamburg-Eppendorf) ; Eikema, D. J. (EBMT Statistics) ; Stelljes, M. (University of Münster) ; Beelen, D. (University Hospital Essen (Alemanya)) ; de Wreede, Liesbeth C (EBMT Statistics) ; Mufti, G. (GKT School of Medicine) ; Knelange, N. S. (EBMT Data Office) ; Niederwieser, D. (University Hospital Leipzig) ; Friis, L. S. (University of Copenhagen) ; Ehninger, Gerhard (Universitätsklinikum Dresden) ; Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ; Yakoub-Agha, Ibrahim (Université Lille2) ; Meijer, E. (Amsterdam UMC. University Medical Center) ; Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Kanz, L. (Universität Tübingen) ; Lopez-Corral, L. (Hospital Clínico Universitario (Salamanca)) ; Brecht, A. (Deutsche Klinik für Diagnostik) ; Craddock, Charles (Centre for Clinical Haematology) ; Finke, J. (University of Freiburg) ; Cornelissen, J. J. (Erasmus MC Cancer Institute. Erasmus University Medical Center) ; Bernasconi, P. (Fondazione IRCCS Policlinico San Matteo) ; Chevallier, Patrice (CHU Nantes) ; Sierra, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Robin, M. (Hopital St. Louis) ; Kroeger, Nicolaus (University Medical Center Hamburg-Eppendorf) ; Universitat Autònoma de Barcelona
The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with myelodysplastic syndromes reported to the European Society for Blood and Marrow Transplantation registry. [...]
2019 - 10.3324/haematol.2018.200808
Haematologica, Vol. 104 Núm. 5 (30 2019) , p. 929-936  
10.
9 p, 855.6 KB Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain / Grau, Santiago (Hospital del Mar (Barcelona, Catalunya)) ; Azanza Perea, José Ramón (Clínica Universidad de Navarra) ; Ruiz, Isabel (Ruiz Camps) (Hospital Universitari Vall d'Hebron) ; Vallejo, Carlos (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Mensa, Josep (Hospital Clínic i Provincial de Barcelona) ; Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Heinz, Werner J. (Hematology/Oncology Department, Medizinische Klinik und Poliklinik II, Universitätsklinikum, Würzburg, Germany) ; Barrueta, Jon Andoni (Medical Department) ; Peral, Carmen (Economics and Outcomes Research Department, Pfizer S.L.U, Alcobendas) ; Mesa, Francisco Jesús (Medical Department) ; Barrado, Miguel (Clinical Trials Department, Trial Form Support, Madrid, Spain) ; Charbonneau, Claudie (Pharmacoeconomics Department, Pfizer International Operations, Paris, France) ; Rubio-Rodríguez, Darío (Pharmacoeconomics Department, Health Value, Madrid, Spain) ; Rubio-Terrés, Carlos (Pharmacoeconomics Department, Health Value, Madrid, Spain) ; Universitat Autònoma de Barcelona
According to a recent randomized, double-blind clinical trial comparing the combination of voriconazole and anidulafungin (VOR+ANI) with VOR monotherapy for invasive aspergillosis (IA) in patients with hematologic disease or with hematopoietic stem cell transplant, mortality was lower after 6 weeks with VOR+ANI than with VOR monotherapy in a post hoc analysis of patients with galactomannan-based IA. [...]
2016 - 10.2147/CEOR.S122177
ClinicoEconomics and outcomes research, Vol. 9 (december 2016) , p. 39-47  

See also: similar author names
9 MAERTENS, Johan
9 Maertens, Johan
1 Maertens, Johan A.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.